Multiple Myeloma Clinical Trials in Goodyear, Arizona

3 studies are recruiting for multiple myeloma in Goodyear, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

    The purpose of this study is to find out whether giving a single dose of tocilizumab before treatment with ramantamig can help prevent or reduce the severity of cytokine release syndrome (CRS) within 28 days from ramantamig, compared to participants who receive placebo. CRS is an acute inflammatory…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    City of Hope Phoenix, Goodyear, Arizona
    Locations
    38 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07589634 on ClinicalTrials.gov

  2. MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

    The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the treatment of MM (a type of cancer). This study is seeking participants who: * Are 18 years of age or older and have MM. * Have received treatments befo…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Western Regional Medical Center, Inc. dba. City of Hope Phoenix, Goodyear, Arizona
    Locations
    270 in total
    Run by
    Pfizer

    See if you can join NCT06152575 on ClinicalTrials.gov

  3. A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients

    This study assesses the impact of cannabis (also commonly called marijuana, weed, or THC) use on quality of life among patients with multiple myeloma who are receiving chemotherapy. It also evaluates the potential benefits and harms of cannabis use.

    Stage
    Not phased
    Ages
    18 and older
    Site
    CTCA at Western Regional Medical Center, Goodyear, Arizona
    Locations
    11 in total
    Run by
    City of Hope Medical Center

    See if you can join NCT07225738 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.